DISCLAIMER: Referring provider attests to assess patients for elevated BGL and symptoms of hyperglycemia prior to infusion and will continue to monitor while on treatment. Referring provider will ensure patients with hyperglycemia or preexisting diabetes are under appropriate glycemic control before and while receiving Tepezza